intermittent low-dose dobutamine administration
CONCLUSIONS: Six-month       intermittent low-dose dobutamine administration was well tolerated by patients       with severe CHF; it did not improve the functional status and did not       significantly increase the mortality rate as found with higher dobutamine doses       in other studies.
CONCLUSIONS: Six-month        @SUBJECT$  @OBJECT$  @PREDICAT$  was well tolerated by patients       with severe CHF; it did not improve the functional status and did not       significantly increase the mortality rate as found with higher dobutamine doses       in other studies.